MedTrace Logo

Growth and Tolerance of Infants Fed Formula for 16 Weeks

NCT03487094 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2020-07-10

No results posted yet for this study

Summary

Growth and Tolerance Trial of Iron-fortified infant formulas

Conditions

  • Child Development

Interventions

OTHER

Infant formula

Multi-centered, prospective, randomized clinical trial

Sponsors & Collaborators

  • Nature's One

    lead INDUSTRY

Principal Investigators

  • Robert D Murray, MD · Consultant

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-18
Primary Completion
2020-07-09
Completion
2020-07-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03487094 on ClinicalTrials.gov